Sanofi wins vax approval; Takeda invests in Fate; Bayer wins fast track status;

 @FierceBiotech: How to play the game of naming new drugs. Story | Follow @FierceBiotech

 @JohnCFierce: Last summer, analysts were valuing EDT at $1B-$1.3B. Wonder what they think of the $960M deal. Follow @JohnCFierce

> Sanofi has won FDA approval of its Fluzone Intradermal vaccine, which uses a tiny needle for injections. Report

> Japan's Takeda has invested in Fate Therapeutics, a San Diego-based biotech which is developing stem cell technology. Story

> Orexigen says it has submitted a new plan to retest its obesity drug Contrave. The FDA had demanded a new study to investigate potential cardiovascular safety issues. Story

> Bayer has won fast track status for regorafenib, an experimental drug for gastrointestinal stromal tumors. Story

> European regulators have signed off on Biogen Idec's plan to start a pediatric trial for its new treatment of hemophilia B. Report

Pharma News

@FiercePharma: Pharma CEOs lost in the executive-pay shuffle. Story | Follow @FiercePharma

> HHS audit criticizes antipsychotic use in elderly. Story

> AZ chief: Industry stats skewed by overstated U.S. prices. Article

> Feds target Forest again with Justice subpoena. Report

> Aurobindo mulls sale of fast-growing API unit. Item

Biotech Research News

> Viruses could solve problem of hard-to-treat pancreatic cancer. Report

> Sexual orientation linked to cancer survival. News 

> Study ties chronic acetaminophen use to blood cancers. Article 

> Stem cells help create blood vessels and save life of girl. Item 

> WV's Marshall Institute means business when it comes to biotech research. Story 

> Scientists rethink serotonin, discover functions outside the brain. News 

Manufacturing News

> American Regent clears one contamination recall, starts another. Article

> Alkermes gains manufacturing strength with EDT pickup. Report

> Zacks rewards Perrigo's speedy QA turnaround. News

> Zenotech strikes over Ranbaxy/Daiichi management. Story

> NJ pharmacist murder draws Purdue reward incentive. News

> Gang poses online as carrier, steals shipments. Item

And Finally... Researchers at Caltech and Ireland's Trinity College Dublin say that a certain region of the brain drives different types of decision-making behaviors. Report

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.